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WORKSHOPS 
(JOINTLY SPONSORED WITH THE NATIONAL PROGRAM FOR DERMATOLOGY) 
FRIDAY, MAY 3, 1974,7:30 P.M. 
Workshop 
Acne 
Disorders of 
Keratinization 
Pigmentation 
Mechanisms of 
DNA Repair 
Tumor Biology 
Immunologic Diseases 
Directoi"' 
Peter E. Pochi, M.D., Boston, Massachusetts. 
Howard P . Baden, M.D. , Boston, Massachusetts. 
Lowell Goldsmith, M.D., Durham, North Carolina. 
Thomas B. Fitzpatrick, M.D., Boston, Massachu-
setts 
Madhu A. Pathak, Ph.D., Boston, Massachusetts. 
John Parrish, M.D., Boston, Massachusetts. 
Jay Robbins, M.D., Bethesda, Maryland. 
Kenneth H. Kraemer, M.D., Bethesda, Maryland. 
B. Allen Flaxman, M.D., Philadelphia, Pennsyl-
vania. 
A. Bernard Ackerman, M.D. , New York, New York. 
Robert E. Jordon, M.D., Rochester, Minnesota. 
Thomas T. Provost, M.D., Buffalo, New York. 
MORNING SESSION 
SATURDAY, MAY 4, 1974, 9:00A.M. 
CHARLES J. McDoNALD, M.D., Providence, Rhode Island, presiding. 
1. CYCLIC AMP ELEVATING DRUGS I:--JHIBIT PROLIFERATION OF' 
KERATINIZl G EPIDERMAL CELLS. C. OELESC't.l':-;E, PH.D.·. N. 
COLBCRN, PH.D .. ' E. DcELL, PH.D. AND.). VoORHEES, M.D., Department or 
Dermatology. University of Michigan Medical School. Ann Arbor. Michi-
gan 48104. 
Rapid cellular proliferation and reduced morpho({enesis in benign and malignant cells as well 
as in psoriasis lesions have been shown to be associated with decreased cellular cyclic AMP 
• By invitation 
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(cAMPI Cultured j(Uinea pa~ epidermal cells were selected aJ> a model ~ystem to study possible 
~o,\lh mhibition by cA:\IP-ele,·atinl! drug«. The rate of D:\A synthesis was u~ed to determine 
gruwth rate in control rulture~ and tho,;e treated with agent!; which increa~e intracellular cA:\1P 
includan~ dibut,•rvl cydic ,\~I P tDBcA:\IPl. phosphodaesterase tPDEl inhab1tor~. papa,·erine 
!PAP) and theophvlhne ITHF.Ol and agents which st imulnte adenvlatl' t•vclase, isoproterenol 
(IPRl and prosta~londin F. , methyl e~ter (PGE ,Mel. Cells wert> treated with drugs for 21 hours 
and inc-ubated with ' H-thvmidine !TdR-'H) at 2:1 hours for onE.> hour. The specifk radioactivity 
of UNA was determined. DBcAMP (10 • to 10 • Ml inhabited cell ~owth by 50 to 9!)'~ whereas 
hut,•rme I 10 • Ml inhibited h~· le,.., than 7m. Thi;. mhilllt1on hy DBcAM P could not he attributed 
to: 1) decreased TdR-'H trans)lOrt anto cells; or by :!) drug tnxicity as detected b' vital dye ex-
cluswn nr cell detachment Grnwth inhibition wa, reHr--ihlt> without altered morpholog\ PAP 
( 10 • to 10 • Ml and THEO I 10 • to 10 • 1\ll also gave du-e-related growth inhibition as did IPR 
and PGE,Me. RadioautographiC analvsis of gram dem.uv after DBcAMP treatment and TdR-'H 
ancnrporation indicated nu S phase anhibition. 
In ('on elusion, the epich.•rmnl cell cycle is probablv mh1hitcd in the G, phase. That hve different 
!'AMP elevating drugR inh ibit ~rowth sugge;,ts th is is specifically due to cAMP. 
2. CHARACTERIZAT ION OF ELECTRO!'J-LUCE. T "GLOBULAR 
BODIE ,. IN :-.JORMAL MELANO OME U 1?\G HIGH VOLTAGE 
AND SCANNING ELECTRO N MICROSCOPY. K .J IMBOW, M.D. AND 
T. B. FITZPATRICK, M.D., Department of Dermatology. Massachusetts 
General Hospital, Harvard Medical School, Bos ton, M assachusetts 02114. 
A new structural ~ubunat, i.e .. globular bodv. nf the normal melanosomr was found 111 fine struc-
tural ~tudieg of melano~ome, in skin. hair. black feathers. and choroid and reunal pigment epi-
thelium of black and alhiml e~·es. Skin and hair were ubtained from Caucasoid~. Mongoloids. 
Negn,ds. black I(Uinea pig~. and mice. A high-voltage <8()() k\") electron m1cro~cope wa~< used to 
observe the three-diml'nsmnal ~tructure of leached melanosome:;. that "ere obtained from treat-
ment w1th bleaching agents and prolonged boilin~t at I :lll0 C' for :?4 hours. The globular bod~. -100 .~ 
Ill diameter. appears tube a ~tructural element that'"' 1ncurpnrated in the organizataon and mela-
nit.atiun of the inner mntri<"es of the melanosomes. 
The~e bodies were fuund to he (al present in all stages of melanosome de,·elopment. !bl in-
crea~ed in number during developmental stage,, !c) at tached to the surface of the lamellae of the 
inner matrice». !dl covert.>d by osmiophilic fine grams nf melanin moieties after melanization of 
the melanosome. (e) nnt melanized during melanns<1me development. <0 unchanged in size in all 
the W•sues examined. ll(l not degraded by phenol. lh ioglyruli<· acid. or prolonged boiling. and !h i 
unimolved in the lyhosumal degradation of melnnosomes in keratinoc)tes. 
3. THE TRANSIT T IME OF SEBUM. M. ABEL., M.D., D. T . DowNING, 
Pu.D., .J . S. STRAuss, M.D., C. W. LEES, M.D. AND P. E. Poem, M.D., 
Dermatology Department. Boston University Medical Center, Boston, 
Massachusetts 02ll8. 
\ltany investigators have studied the rate at which .,ebum IS produced by the sebaceous glands 
and have attempted tn manipulate this rate as well as the composition of the li pid produced. How-
ever. there has been no report r>n how long it Lakeb for sebum w reach the skin su rface after it is 
synthe~ized and. therefore. how much delay might he expected between anv change m ~ebum 
svnthesis and the manifestalum of this in lipids collected from the skin surface. \\'e have no" 
measured this delay in 2 .. beep and in 4 humans. Following the intradermal injection of [l -"Cl ace-
late I I I'Cil in each species, -.u rface lipid was collect ed dailv from the injection sites for up Lo 21 
days and the weil(ht and rad11>aCtl\'ity of the samples were measured. Thin layer chromatography 
was used to analyze the hpid samples and also to fractionate a major part of each da1ly collection 
into the constituent lipid classes for determination of the specific radioactivities. Two sites 111 
each l>heep yielded a peak nf racl ioactivity in the total su rface lipid. as well as in each constituent 
lipid class. 6 days after mject ion of the labeled acetate. The human subjects showed a peak of 
radit~~~ct ivity in the total su rface lipid. and in each lipid consti tuent. 8 days after inJection. These 
delav periods presumably represent the Lime taken fur sebum to reach the skm surface after it 
ill synthesized. It remains to be determined what proportions of this time are spent in intact 
sebaceous cells and as free lip1cl in the pilosebaceoub fol licle. 
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4. PEMPHIGU ~ ANTIGE~S [)i HUMA'\1 SERA. E. H. 8Et'T..,ER, PHD .. 
R. 'PORER, M.A.· AND T. P. CHORZELSKI, M.D.·, Department of Micro-
biology. tate University of ~ew York at Buffalo. School of Medicine. 
Buffalo, New York 14214, and Department of Dermatoloh'Y· School of 
Medicine, Warsaw. Poland. 
While the rise in tiler ol pemphigus antibodie, pren•dt·' the renppearanre ot hullnu~ eruptions 
tn mo"l ca,es ot pt>mphigu,, thi;, sequence i.-. rcv~rsed in ,nme l"tt'e". In the•!' CthC' the frc,h 
relapo;e -.ern mav be ne~:atin• 111 standard immunuOuure:.nmt t iFt te>.ts for pemphigu• antibodies 
while .;ample,. taken 11 lew dn'·" later are ,trongl~· po,itiH'. One ~uch "nejlntive frl·~h r~;laJ>'-e·· 
J>crum was ;,tudied in detail with an IF absorptiun te'l tur nnti!len. with surro-.e den-it\' J(l'lldient 
for .-eparatton ot pemphti?U~ nnttgen and of immune l'omplexe,., wnh heat inactJvntmn ol tmmune 
nunplexe>. for relca~e nt pemphigu" nntibodie' from 1mmunt· cumplexe" and with \lunrini typt> 
roclinl diffu~ion aMsav lnr l~tC. The~->e method~ revealed thl.' prehen<·e of pemphlj.,'US antil(l'IHlnti· 
hndv t·umplexes m a nel{nl1ve fresh relap~e serum and pemphigus antigE'n alone 111 normal sera. 
Specitically. absorption t~st:. rc,ealed pemphil(l.ls antil(cn in IF ne~tntive sera The ullrarentrifuge 
mubility ot anlt~ten in nnrmol ~crum corresponded In thnt uf nlhumin nod nf r>cmphtgus antigen 
l'XIracted from human esophn~:us while the antil(en in the tll'gatin• fre!<h relapsl• -.erum wa" the 
IIS!me us or hea\'ter thnn that nl normalle:G and wa~ nn·ornpaniPd h,· II(G HE'at in;tcti,ation for 30 
minute at so•c nf either the whnl~ negatiw fre-h relopw ,prum or ot it-. antigen rirh fraction 
from ~ucro'e density gradient ~entriful!'ation revealt·d tht• pr~cnce ol pemphi~:Us .1ntihodie,. in 
--tnndard IF te~>ls. 
5. PHOTOPROTECT!Oj OF FIBROBLASTS BY BETA-CA({OTENE IN 
VITRO. P. FRITSCII, M.D.*, F. GSCII NAIT, M.D .. . H. HON IGSMANN, M.D .. 
AND K. WoLFF, M.D .. Division of Experimental Dermatology. Department 
of Dermatology I. Umversity of Vienna, A 1090. Austria. 
The unre>-olved met·hnni'm of i:I·Cnrotene lbCl photoprutcctinn in porphvrias ha,., 'timulated 
in \ 1tro studie. empluyinK ht-matuporphyrin !HPI-st'nsili7ed fetal bovine hoof libruhlasl!> IBHFl 
ancllong wave U\ . irmdiutinn tl1\'l a:. a model s~·stem. HHF tolerate l'\' well wht>rt'BM HP-sensi-
t IZE'd BHF undefl(o lelhnl del(cneraiion accordtnl( to two dtsltnct and separable pattern~: II mem-
brmw-dependent C\'tnlyllis due tu a re\ersible sensili7ation uf cell membrAnE's; 21 C'\tnpla,.,mic CE'II 
damuge by non-reH•r~oiblt> t·vtnplo)<m ic ~ens it izalion The dural um of H P-t rent ment determine!. 
whether mcmbrunenus nr c~toplosmic sensitization occur~. 
Tesltnl( of hC tn lht~ Ry~>H•m rc,eals: I ) premcubatinn uf HHF 111 hC prtor lCI HP-sunsi tization 
pmvides moderate prntection trom l'\'; 2) the de~tret' ul thi' protection increase.,linellth w1th the 
duratiOn of bC trE'atml.'nt reiH·htnl( a ma.ximum utter 7 day~: :lJ bC-protection i~ maintained eHn 
nfH•r trvp,•inization ut BHF nnd withdrawal of bC tor:!~ hour-.; II protection ts at·hiro,·ed a.:ain~t 
both pRttern!-. ot cell clamal(e detnil~;d abo\'e: .'il hC I rom the ~era ot bC fed normal \'olunteer, ofler.. 
better protection than hC di-.-.ohed in \'itro; and 61 HP-,ensiti7ed BHF ~how red diflu•e tluorc~­
cence wherea<> BHF incubated in hC prior to HP-sen~itization do not. Some ol thc,;;e data indicate 
that bC' acu., nt least in part. 111 tht le\'el of the cell mtmbrune intn which it nppt>ars to hE' incorpor· 
ated 
6. ISOLATION OF AN fMM~OLOGICALLY ACTIVE FRACT£0N 
FROM THE BASEMENT MEMBRANE OF HUMA~ SKIN. W. T. 
SUMMERLIN, M.D. AND R. E. JoRDON, M.D., Department of Dermatology. 
Memorial Sloan-Kettering Cancer Cenler. New York. New York 10021. 
and Department of Dermatology. Mayo Clinic. Rochester. Minnesota 
55901. 
Evidence obtained trum studyin~t diseases such as ~Yt<temic lupus erYthemato'u~ and hullous 
pemphigoid (BP) indicatt>~oo immunolol(ic activitv in the b!IHI.'mt>nt membrane tBMl of human skin. 
ThE' purpo~e of thi~> study wa .. to isolate the actin> onltjlentc C<lmponent of such reactions from 
an extract of human cuton~nus RM. Using ultm·thin fre~h ct~daver ~kin obtained with a derma-
tome the BM wa'l mel'honit•olh: isulated by ~omcntion und ~l!ntrtfugauon. The lyophiliud crude 
BM tsolate Wlb then subjected to progressive chemkul di~te,tion u,.ing prona~e and Sodium 
hydroxtde: al(ai'O!<e column t:>.traction followed reduct inn and alkylation. Fractions were dialyzed 
and lyophilized. Result' rrveal a soluble glycoprotein tractinn which has specific identity with 
PROC:RM•1 
!ll•\·crnl h1.:h tilered BP £>ru u~inc complement tn.auon, hcrnn$!J:lutmauon. Ouchu•rlony ond 1m· 
munoclectropho~-Is. The acthc immunochemif'ftl troct.lon is now undel')toin~: purif1r.ot•on and 
dlBrDt1t·ri7.alino \\"t· runcludc that nt lca,.t one molecular romponf:nt ol human CIJIDIII.'fiU B:\1 
rnR!lllt·~•~ immunuchumrnl nrth II) and that -uch n mnlccull' rna' repre:.ent the not ural or dt 
nnti~:t·n thouj!"bt to bt• 111\ul\l•d 111 autoimmunl' di~l'A~lH nl the <·utaneous B:\1. ,\ ~ouch 11 '"'"ld 
n•pti'M'Ilt the fir.-t naturulunti!(l'll 1 nluted !rom sk111 . 
7 THE SUBSTIWC"I'lJHE AND CH8M IC 'AL NATURE OF TilE IIOHNY 
C'ELL ~lEMHl{A:\K A. G. :'vlATOt.T!'\', M.O Department ol Dt:rma 
tolo~. Bo:.tnn l tllnr-.tl\ chool nl 1\h·dkine. Boston. l\ta,...:-.nchu:-etb 
0211 . 
H•m1y cell, of the 11\llnllnalinn epadt•rtnl." an' kno\\11 to be prua-cted b~ a 11111oma mcmhrnne 
"ith 11 den~ mut<·rinl dq>mJtl'rl l•n it!- inner ~url.tlc. I v dumh terite thl" prnll·cliH• matcrtlll, 
mNnhrnnc.- of horn\ n·ll~ "''rt' u>(llllll·d frtlm tht· nl\\, chu·k nncllrug t>11idernu~ by tht ll~t· ut IJ. I 
"'I '\;nOll Detatled clet·ltnn nunn~nl]>l' ~tudies hnn• ~huYon thnt th£' 1wlated insuluhh· tnl'rnhrnn · 
11\lh tnllterial corre~pnndR tu tlw dt•nw hand seen Ill .~till 1111 llw lllllfr ~urtace ut till' plnHmn lllt'lll · 
hrun<· nf horny cells. Furtlwrmnn• hnth tsolared mllh.'rtnl unci th·n '" hand in .~itu n•nlltMt ul liO .~ 
J>llttich·~ Pmbedded intu nn onwrphuu-. m11tri10 . .\minoadd .mah'titS h.a~e >ohoY.n that <'\"lt•111e n.- • 
irlue~; r.mge lrom 18 1•1 411 per 10110 re~idue:.. Prolim ~~e the hiR}lest ,a]uc in roY. rnt!mbrones 
(lji'/IO(lO), glycine m 'hick Jn(·ntbranb (363/1()C')(Jl ond glutumtc acid in frO!! mtmhrun~ (16-11 
10001 It i.; cconcludl!d. thAt n•rtchrath are protecte-d b} a h(ghly . tatulized amorpoou tJbstan~ 
wtth a granular .. ul):.tructurt• rt'!!tdingm the thickened uua•r J>llrt ot tbl:' horny .:ell membrane. The 
prutt•in• participalln~ tn tht• lorm•ttion of the protecll~e matt>rinl hppear to hl' difh-rrnt in Writ'· 
brut 1 111 \'ariou.~ da'>!i< . 
H. PREFERENTIAL CUTANEOUS lNPJLTHATION BY Nf~OPLAHT!C 
THYMU '-DEHIVED LYMPHOCYTES. R !<:nELSON, MD . (' KtRK-
l'ATRICK. ~1.0 · fo: SitE\ ACH. M.D ·. T. Y o~lllllA. :\1.0 ·. \1. Lm'l.NER. 
~1.0 A~D l. GRt:.t:!'.. \1 D :\auonal Cunn•r Institute and ~atiunnlln!'ti· 
tute of Aller~: :md Tnfectiou~ Di-.en::-l'. National Institutes uf Health. 
Bethesda. ~larylaml 20014, and Departml'tll of Pathology, Uni\'cr:-ity of 
Buflalo. Buffalo. ~l'\\ Yurk 14:214. 
lu uwc~t igate wheth1•r nt•tlflllli<t 11 lvmphoc.\ te,., whit h lltl'll'n•nt iall\ mfilt rutt· thl' ~kin hnn· 
n•mlll()ll feature•. \H' ~tlltli!'tl till' ilhnurma!Jymphucylt•!• 111 1(1 pntil:'nlS with lvm phoprn!ait•rnl iw• 
tla.urtfl,r:. dt,.ltnl!\ll"hl•d hy ~·~tl'II•IW (Utaneous tn\ul\t·nwnt l'ht· neoplastk t'lrculutint nils 111 
c.u II ul 7 erythrodermi1 Jl.'ll !t-nt a w tth h mpbon 1 k l(·ukcmiu ol d11lt'rent morphoii)J(ic type• muld 
bll tdtntitieod & thymu~·dt•rauod 1 1'1 <ell" by lormnliun uf ;.pontum-ou' ro~ttes with Jhec·p cl) th 
I'OC\ tes and the pro:"ol·nn• ot Jlt'Calil membram• nntigt ns. The ltukewk cell- from one ol the;;c 
patient..-. al,.o had comph:me!ll rNl"pton;. a charonensur c.f lxme marmw-derhed (AI t'ells The 
ahn• rmnl ceJ!, intiltraung tof\'throdc·rmit -.km in thr i h·ukemtc p:uient' and plnqu("' 1113 plluent 
wtth m~cMI. ... fun~:uiue- \\t'TI' alw shuYon to hau T nil lllt'tnbrttnl' prop.:rtit·. h\' 11 anrth•lri prl'· 
\IIIU~ly Ul'scrihed [,J lnH 1 l>t.'rm 61 :8'!, 19731. Tht• lailurc• ollyrnphncytes frc1m :1 fiBlit·nt- \dth T 
n•lllt•ukemia to rt'spund Ill mitn):t'll~ t:nrrelated \\tlh tht ir unr~•IJIIII~ivene~, lu alln.:en!'tl'l\mtlhn 
•'Ytl'~ 1r1 mixed lcukucvlt' t•ullllf('~ IMLCl. Leukcmir T n•ll> fnun I patient fnih•d 111 stJOIUiutc 
llllo!(C.'IIl'ic lymphnt·yte~ in l\IU' tie-pile havinl! at lull mmpii'Inl.'nt ol HL-A anltltt'll .. ~UPJh'rtlnf' 
tht• u.:~:ested separation t•l tht:-·1 ·• historompatibilsty ystcm~. Sero and lymphocyte supcma 
tllnll; I rom each ol ltt.,ll•d Jl<Hir.ntl! \\lth T ce111eukerntn l'(IOtained Jar;:~ amount.o; olma"rophnge 
migmtton inhabitnl) l.t•'t(lf. IAmphoprvli.tl:'rati\'1.' di1wrdcr with widL-...pread t:utarli'OU tmohe· 
mtnl nrtl trequently T t't'll mnlignancie- Y.ith :<e~ual dl tin~!~Ju.hang rt'llular fl'atur . 
B. EFFECT OF liP([) SOLl.BLE ESTJ.~HS OF ~IETHOTRE>.. \IE 0:--. 
D'\A SYNTHES!~ 11'1 HllMAJ\ SKI\i ,J L McCUJ . .LOUGII, Pu.D. · ""'n 
C. D. WEINsn:IN, M.D, Department of Dcrmntology, Univenuty of Miami 
~·khool of Mecliclll<'. Miumt, Florida :tl lfi~ . 
.\lth•·u~h ~ystemicall~ ndmint. tt·red methotr.,\att• \.\IT:'\1 l~ cxtreml:'ly ellecti\t' m tht thtrap' 
ol pwria-i,, ih U>l' tn1>i1nlh· hll• heen clinia~lly in~lh·Ctiv<. ,.\ &tudy was de&i11ned tn <'ompart: 
•nhalmiun oi D~A ~vnthl",.l~ m human epidermi• by lipid tiOlublt.• analoJtUl':- of :\ITX nnd other in· 
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htbil.on. of dihydrofolotc reductru;e to find a potentially u~eful topical agent . DiHerent human skin 
'lllmple!> were each preinruhatt>d for :JO mmute,; with Ill • M concentration of 11 ~eril'~ of 11m com-
pounds. The inhtbitton ol D~A synthesis by thet~e compounds was as..>;ayed by addin~ deoxy-
uridine-•H fo r 2 hc>urs and then measuring it~ incorpomtion mto extracted D~A. A rotio of mhib· 
itory acti,·ity expres::.cd as the •·, tnhtbition by 10 • M dru~ to the '• inhibition by 10 ' M MTX wa~ 
calculated for each compound. Maximum inhibitory tu•t ivity was obtained with the dimethyl and 
diethyl esters of MTX. and the same esters of dichlnromelhntrexate CDCMI, with ratios of 1.40, 
1.42. and 1.47. 1.·17, rc,peclt \l'ly. Further int•rt>a~es m alkvl t•hain lt>ngth resulted m a decrell!oe 
in inhibitory activit). Hauos obtained for other comJXlund~; wert> DCM (1.261. aminopterin11.38), 
pyrimethamine (0.2;i) and trimethoprim !0). It i~ not known yet whelher thebe results reflect dif· 
ference,; in cell penetrutiun due to lipid solubility variation~ and/or binding nl the dru~ by dihy-
drnfolate reductase. Thest- po~,ibilitie,. are present!~· under in' esu~ation 
10. INDUCTION OF SKIN TUMORS IN HAIRLESS MICE FOLLOWING 
SINGLE EXPOSURE TO ULTRAVIOLET RADIATION. L. C. HARBER, 
M.D., J . Hsu, M.S.· , P. D. FORBES, M.D. " AND E. LAKOW, M.S. •, Depart-
ments of Dermatology, Columbia Uni\'ersity College of Physicians and 
Surgeons, New York. New York L00~2. Ne" York University School of 
Medicine. New York, New York 10016, and The Skin and Cancer Hospital. 
Photobiolo~n Program. Temple Uni\'ersity Health Sciences Center, Phila-
delphia, Pennsylvania 191·!0. 
Numerous studie~ have demonstrated cutaneou;., carcinogenesi~ following multiple U\ ' expo-
sure. This study reports the mduction of ,;kin tumor~ in 62 ot 139 hairless mutant {hrhrl mice 
following a single exposure tel ultraviolet radiation tlJVRl. :-.:one of 59 unirradiated contrul mice 
developed any growths. Tumor.• were first noted a~ eurlv a!\ ~even to ei~:ht weclu> following irra-
dtatton The UVR. emitt ed by FS20/40Tl2 nuore~cent lamp~. was principally in the 28U ~20 nm 
spectral region with a peak at 300 om. The oncogenic effect of a s ingle (skm bUrfacel dose of 
3 10' Joules/m' to 12 10' Juule:;, m 2 was tO\ e~ t igated. Higher dosages resulted m more se,·ere 
acute damage as well u~ a lfTCater tumor yield. Both papilloma-. and squamous cell carcinomas 
were observed followmJ( U\'R exposure. It i~ roncluded dun Lhis system aftord, an oncogenic 
model which does not requm• multtple expo:mr!!!> or promotion by chemical agents. 
AFTERNOON SESSION 
SATURDAY, 1:30 P.M. 
KtRK D. WuEPPER, M.D .. Portland, Oregon. presiding. 
1. POLYPEPTIDE COMPOSITION AND ORGAr IZATIO~ OF EPI-
DERMAL PROTEIN . L. D. LEE. PH.D.· AND H. P . BADEr., M.D., De-
partment of Dermatology, Massachusetts General Hospital and Harvard 
Medical School, Boston, Massachusetts 02111. 
The a-fibrous protein» of the epidermis (prekerat in and s trat.um corneum proteinR) ha\ e been 
shown to consist of se,·eral polypeptide chains. Prekeratin is extracted from ~:ow snout et>idermis 
wtth 0.1 M citra te buffer. pH :to. and purified by prectpttalion at pH 7.0. 6.0, !;.0 und 4.5. The 
stratum corneum protein i" prepared by subsequent extraction of the epidermt>. with 0.1 M tris. 
pH 9.5. containin~t 6 M urea and 0.1 ~~ mercaptoethanol The various polypeptide chains are tden-
tified by SDS electrophore:.is. Using DEAE chromato~trapby tl has been possible to tsolate these 
subunits wilh a high degret> of puril) from prekeratin. Four ~ucb chains have been identified fA, 
A', B. B'l. The A group. ha" u molecular wet~ht of about 60.000 and the B group about iO,OOO. 
X-ray diffraction analy~> ib of rhe isolated chains 11how~ no evidence of cr-helicnl litructure while 
the mixture has an n-hclical pattern. Definite diJferenceh in amino acid composition exist bet ween 
lhe A and B families; however. the amino acid content of lhe memberb of each group are almost 
identical. Similar resuiL~ have been obtained with the s tratum corneum protein. 
These results show that the a-protein of cow !tnaul epidermis is comprised of several dt.stinct 
polypeptide chains but further work i.s necessary to eluctdate the organ ization of the ... ubunits in 
the prekeratin molecule. 
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2. EPIDERMAL TRANSGLUTAMINASE: BIOCHEM ICAL AND IMMU-
NOC HEMICAL ANALY"' I . M. M. Bl'X:>.IA11- AND K. D. \VLEPPER. Univer-
sity of Oregon Medical chool. Portland. Oregon 97:201. 
Covalent t·I.·JdutamvH (_,sme bnnds. formed by the actmn ut transglutamma~es . have been 
demonstrated in prot ems of keratinized ti~~ue. In order In studv the rule nf trnns~:lutaminn~es in 
keratimzing tisbue. epidermal transglutaminase !ETI was purahed from tris-;.aline homogenate, 
of (•nw snout epidermis. Purificm ion required three steps Sephadex DEAE A-511 chromatugraph~ 
at pH 8. electrophoreiiiS 10 Pevikon at pH 8.6 .• 1nd ::iephadex G-200 gel filtration. The punfied 
protein gave a single band in acrylamide gel electrophore~is in the presence of OTT. SDS and 6~1 
urea It had a sedimentatwn coefficient of 4.-l.i Sand u molecular weight ol55.000 bv analvucal 
ultracentrifugation and gel permeation chroma10graphv Purified ET incorporated th<> llu<>rescent 
amine. danliyl cado,erme. inl!l ca~ein linearly with time The reaction was dependent upon tern· 
peruture. pH. enl~·me concentration and calcium. 
Mcmospecific antiserum to ET. elicited in goats, prt'cipitoted in agar against crude nr high!\ 
purified ET and inhibued the ability of ET to cross link rilmn monomers. The antiserum did nut 
cross-react with pla~ma transglutarninase (coagulation F'aclor XI Ill. nor did it inhibit fihrin cross-
linking by X lll. Conver~<'lv. antisera tu Factor XIII did nut mteract with ET. ET was purified. 
characterized. and dihtingui~h('d from plasma trans~tutnminnse. 
3. LEUKOCYTOCLASTIC \' ASCUUTIS: BLOOD VESSEL ULTRA-
STRUCTURE IN Ii'\VOLVED AND UNINVOLVED KIN. E. G. TuOR."'E, 
M.D., W. M. SAMS. JR., M.D. AND J. TEINBURG'. Di\'ision of Dermatology. 
University of Colorado Medical Center, Denver, Colorado 80220. 
Previous ultrahtructural studies ot leukocvtoclastic- va~culatb have dealt w1th invol\'ed skin 
and ha,·e shown on!~ the later <"han~e!oo of vasculitis. By includmg biopsie!oo of normal !ikin adjacent 
to the purpuric lesions we hoped Ill determine the evolution ol \es.~el alterations. Addataonally. 
a search was made for antigen-antibody complexes and ,•ira! particles which would have been de· 
stro~·ed in later pha~es of vasculitis. 
Fourteen biopsie:o were obtained from se\'en patient~ ''ith clinical and histologic evidence ot 
leukocylOclastic \'asculalls. Riops1cs were prepared in a mullne manner for hght and electron 
micro~copy. Suitable t·ont rul biopsie;o were also examined. 
The earliest change M~en in climcally uninvolved skan wa~ endothehal cell h\ pertruphy wath 
increased ve;;icle forrnatinn and with long \'illou~ pmcesse~ which bulged into the lumen sug~e~t­
ing increased phagocvtns1s. In a later phase numerous polymorphonuclear neut rophils in variou:> 
stages nl karyorrhexis were seen surrounding the blood vessel t\('tual dest ru('linn of the hlood 
vessel wall by polymnrphonuclear neutrophils \\liS not nntrd Generolly. the bl(l(1d \esse!~ from 
purpurir le~ionl> appeared intact , hut adjacent tn the hlcK1d \'essels there was clearinF, away of 
cellular debras and fibrm deposih h~· monocytes and hhrnhlasts. '\either nral particle, nor 
anti~en-antib<><h complexes \\ere heen. 
4. T HE ROLE OF LANGERHANS CELLS IN C'Ot'\TACT ALLERGY. 
I. SILBERBERG, M.D., R. L. BAER, M.D. AND s. A. 
Department of Dermatology, New York University 
New York, New York 10016. 
ROSENTHAL, PH.D . .• 
chool of Medicine. 
Reaction~ to D:'IJ("B in pas~ively sensiuzed guineu pigN were ~tudu?d h~· electron mkro5cupv 
to further define the rnle nf Lan~erhans cells !LCI in mntact allergy. Passive transfer wa~ done 
with o) DNCB-~ensill\l' peritoneal exudDte celb: bl both 0:-.JCB-sensi!lve pentonenl exudate 
and lvmph node cells. cJ 0'\C'B-senl'itive spleen ('ells; dl 0:-JC'B-sensiti\e lvmph node tymphu-
cytes; and e) non sensala\'e lvmph node lymphocyte~. Experiments al dl resulted 111 DNCB 
contact-allergy in the re<·apaents, the earliest chan~te being the appearance ut LC' 10 the derma~ 
a hour~ after challenge. The cvtoplasm of ~orne of the~e cell~ ~hnwed many lv~osnme- like hod1e>-. 
fine filaments and much endnplasrnac reticulum Mononul'lear cell~> !MC) were found 111 apposition 
to some of these LC. Altt>r 3 to 19 hrs. dependin~t on the number ut lymphocytes inJected, :VIC to 
LC apposition was seen in the epidermis as well. LC "ere al•o tuund around vessel5 ond in the 
lumen of a dermal vessel In experament eJ. LC' were roreh -een 111 the dermi• and MC' LC' appn· 
sition and change!! in the LC were not seen. Thus, in passively induced contact-allergac reactions. 
in contrast to active sensitization, changefi in the dermib predommatt>d. 
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11. BASEME~T MEf'.IBRA~E ANTIDODY. THE DISTINGUI HH\G 
CHARACTERISTIC BETWEEN RHEUMATOID VASCULITIS A~D 
SYSTEMIC Ll.PUS ERYTHEMATOSUS. A. L. ScHROETER, M.D .. D. L. 
CoNN, M.D.· ASU R K .JoRDON. M.D .. Department of Dermatology. Mayo 
C'linic, Rochel'ter. Minnesota 55901. 
Rheumatoid arthrit is (HAl patient:< 11 ith sy!itemit· \'ll!<culitis hnving clinical ancllnhnrutury fea· 
lures of ~y,.temit· lupus Hythrmato"u~ (SLEl prev111u~ly ht\\'P been a diagno:.ltt· prnblem. To 
differentiate RA 11ith and withnut va<~culitis from ~LE. clin•ct immunotluoresct>nt 'tuclies were 
performed on skin hiup~ies utili1ing monnspedlk conjugates for IJ!G. lgl\1. \~1. Clq. properdin 
ancl fibrin. Twenty-~t·n:n hospitnli7ed RA patients, 1'7 with vn'<t'Ulitili and 10 unt'omplkated. 
wcre t·ompared with 18 pntit"nh wnh SLE. 
Gmnular basement membrune dep<n>il~ of lgG. lgM. C:i, \lq and properdin wen• found in biop-
sies nf involved ~kin of SI.E patient~ stud ied ln mmparisnn. t.'l ol27 patients with RA hod only 
cutaneous vascu lar deposits nf lgG, lgM and complement lrlq. C:~. properdin\. F:le1e11 uf 14 RA 
pntients with dermalle~;inn~ nr motor neuropathy harl vasrular immunoglobulin!\ and complement 
dept~~ its. Only two RA put ient~ pre~enting clinicnllv with mixed me~enchymal disl'OR{· procc~s 
had basement memhran~ a!o well lh vessel depostl~> . Thus. dtret•t immunofluorbrent studie~ 
help differential~: SLE lrum HA with va~culiti.-. 
6. COMPARISO'. OF I~ VITRO CHEMOTACTIC' RESPO'\SE OF HU-
MAN AND HABBIT POLYMORPHONUCLEAR LEUKOCYTES TO 
PROSTAGLANDINS .• J. L. DIAZ-PERF:Z, M.D .• M. E. GOLOY'IJE, M.D. AND 
R. K. WINKELMANN, M.D., PH.D .. Department of Dermatology, Mayo 
Clinic and Mayo Foundation, Rochester, Minnesota 55901. 
Because prosta!(landins are recovered from cutaneou~ tnflammation in human>. and other 
mammalt;. the effect of these ~ubstances on chemotaxis of inflammatory cello; i~ important to 
evaluate Kaley and Weiner found that PGE, was modl:'rately chemotactic for rabbit polymorpbo-
nuclcnr leukocstes IP:-1~ >1 In an attempt to wnfirm their findings. we repeated their -tudies 
and extended them to includE' el'aluation of the effed ol J>GE ,t the major pm~taglandin rl'('I>Vered 
from human and mnmmalian ,.kin) on the chemotartir rcsp<m~e of both human and rabbit P:V1~s. 
Rllhbit PM:\s from glyru~en-induced peritonealexucl11H·!> nod human PM:-.;s ~epnntted by gelatm 
se<hmen tation were used~~~ mdicator cells in rhemotnctit n~says that employed the !\lirropure 
niter technique in mortified Boyden chambers. 
lnit1al results with rabbit PMN!< appear to confirm thl' results of Kaley and Weiner llnwever. 
human PM:--s. while demon~trattnl! marked chemotactic rf.'l;ponse to human sera and t·asein. 
con-.i~tentl~· foiled In re~pond to prostaglandin~ E 1• E . F 1 ., and F... This lack of chemmartir 
r<•;.pon>-e might be explained on thl' ba~is of minor platel~t ronUlminatton of the human PM:-.:s 
"hirn. through local pro~taglandin produclion. could abolish thP chemotactic gradient. However 
thi, possible platelet contaminatinn did not mterfere with the response to other r hPmotactic 
agcnts Thus. our study ,;uggl';;ts that the chemotartic anivity of human prostaglnndin,; i" not 
!lignificant in the inOammotnry re!lpon~e. 
7. IN VITRO QUANTITATION OF CELL MEDIATED IMMUNITY BY 
NJTROBLUE TETRAZOLIUM (NBT). G. G. KRUEGER, M.D.,· B. E. 
OGDEN, B.S.· AND \\'. L. WESTON, M.D .. Division of Dermatology, Uni-
versity of Utah. Salt Lake City. Utah 84132. 
In the cell medtated immune IC:O.HI "YStem, lymphocytf.'l; from l>f.'nsitized guinea pil{s. incubated 
with antigen. manufacture and release MIF into the supernatant These :\.11F supernatants will 
dmmatically increa~e hexo..-e monopho~phate •hunt I H\1PSI activity of nonbensiti7.ed macro-
phages rMPJ. We hll\'e found that C'MI can he qunnlltatcd by measuring the amount of "'ADPH 
diaphorase. the rate lim1ting enzyme of the HMPS. tn MP mrubated with MIF m vitro. In the~e 
M P, NBT is redured to 11 hlu<' preripita1.e by NADPH diaphorase, thus quantitating on a one cell 
hnsis the degree of activntion due to MlF. Assay~ are perfnrmed on a chamber-slidt' Ubing i 10' 
MP/a"-"~~Y · Percent :-.IBT I I,.,.. ( ) cells are counted at IOOOX. The paired t te11t in 108 indirect 
""~ays comparing MIF to cnntruls shows !'ignilicance tp< 0.01) The direct as.•ay with sensiti7ed 
PEC' routinely show,. a 100'lf increa~e over control. Our a~say correlates better with skin test~ 
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than the macrophage aggregation (MAF) assay for CMl: lndirect-MAF 2/6: NBT 6/6: Direct-
MAP :V6: NBT 6/6. 
Advantage~ of this assay are: IJ the number of MP al'tivated by MIF' can he quantitated di-
rectly: 21 it appears to be more sensitive than other a~says for C' Ml : 3) reproducible results can 
be obtained with minimum technical abilit~; and 4) a permanent record 1$ retamed in the ~!ide. 
8. METABOLISM OF PSORALENS. M. A. PATHAK, P H.D .. F. DALL'AcQUA, 
PH.D.*, G. RODIGHIERO, PH.D.* AND J . A. PARRISH, M.D., Department of 
Dermatology, Harvard Medical School, Boston, Massachusetts 02114, 
and [nstituto di Chimica Farmaceutica, Universita di Padova, Padova, 
Italy. 
Ver~ little is known about the metabolism of photosensitizing psoralens. The kinetics of ab-
sorption. metab6lism and excretion of psoralen~ were studied in mice and human volunteers. 
Groups of mice received 0.25 ml 'H-psoralen (PS, 2780 m M/ml, S.A. 4.33 > 10• DPM/mMl and 
' H-trimethylpsoralen <TMP, :\920 nl\1/ml, S.A. IO.fi 10' 0 DPM/ mMl either mall~· or mtrapen-
toneally. Urine. blood, feces. ~ki n and viseera were oh1aineci at 2, ~. 6, R, 12, 24 and -18 hours. PS, 
TMP or their metabolite> were extracted and analy1.ed fo r radioacth·ity. Over 70o/r PS and 88"i 
T MP, after oral or intraperitoneal administration. were excreted m the urine within 8 hour~ and 
over 90"1 within 12 houl'!i. Distribution patterns of PS and TMP radioactivity obtained at diJferem 
time intervals in blood and variou~ organs (liver. skin. heart. lung. brain, intestines. kidney, 
spleen. etc.l revealed 1 hat hoth psora lens were $elet·t i\·ely present in I i,·e r. skin and blood and 
were harely detectable in other organs. Highest ,·alue~ were obtained bet ween 2 and 6 hours and 
diminished rapidly thereafter. Both PS and TMP were metabolized in liver and excreted in urine 
as "everal dist inct f.luorescent metabolites. two of which appeared to be hydroxylated moieties 
of PS or TMP (hyd roxylat ion at :3 position in PS or TMP). Gluturonides of psoralens could also 
be deterted in the urine. l 11 men receiving -10 mg of unlabeled PS. TMP or 8-methoxypsoralen. 
cutaneous photosensitization by 320- 400 nrn occurs maximally between 2 ·-1 hours and is absent 
after 7 hours. 80°i of administered psora lens are excreted in the ur ine within 8 hours as hydrnxy-
lated or glucuronide derivatives. 
9. STIMULATION OF 'T'YROSI~ASE ACTIVlTY BY TRIMETHYL-
PSORALEN AND ULTRAVIOLET IN PIGMENT CELLS. D. M. CARTER, 
M.D. , P H.D .. J. M. PAWELEK, PH.D.*, E. S. CoNDIT, B.S.* AND N. G. KocH, 
B.A. *, Department of Dermatology, Yale University, New Haven, Con-
nect icut 06510. 
Phntomediated bind in~ of psoralens to pyrimidine moieties in Dt\A C"orrelates with phototoxic 
cellular and cutaneous responses, but the mechanism by which psoralens and ultraviolet radiation 
( UVR) promote cutaneous pigmentation is not understood. We ha,•e shown that with UVR 
(365nm), 3,5'8 trimethyl-pgoralen tTMPJ covalently binds to D:'\A of murine melanoma cells 
produc ing single-stranded and cross-link in!( photoadducts in cellula r D:'\A. 
Cloudman m(tuse melanoma cells (NC'TC' CCL 53) in closed. culture tlash containing TMP 
(3 1:3 A 10 3 M in F- lO medium) were irradiated (365om. IUOer~s/mm'/secJ tor .')-20 minutes. 
Fresh medium without TMP was added and . afrer 24 and -18 hours. tyrosinase activity was deter-
mined by the method or Pomerantz {!;cience 164:8:38. 1969). Cells exposed to TMP and UVR 
appeared darker and showed a 2 to 8-fold increase in tyrosinase act ivity when compared with 
controls. Neither TMP alone nor irradiation alone produced an increase. Tyrosinase activity was 
proportional to TMP concentration and lo UV dose. T MP and UVR also increased the stimula-
tion by f3 MS H (10 'M) to tyrosinase activity in these celb. These data suggest that increased 
pigmentation al'ter exposure to psoralen~ and LNR. such a" is seen in vitiligo. is at least par-
tially due to a direct s timulation of tyrosinase activity in irradiated melanin-producing cells. 
:347 
